CSO @Intelliatx 🇺🇸🇦🇷 #GeneEditing #CRISPR #WomenInSTEM Opinions/likes/RT mine & not endorsements.
Boston, MA
Joined April 2014
- Tweets358
- Following349
- Followers968
- Likes1.7K
Thrilled to be back on the board of @OTSociety and honored to be President Elect for 2028-2029.
Awesome to work with @Rebecca Miles, Alexis Secka, the board and our #OTS community to accelerate oligo Rx breakthroughs!
Thank you to all our members who voted in the recent election!
We are pleased to announce the new OTS BOD for the 2026-2027 term.
2026-2027 OTS Board of Directors
Learn more about our new BOD at
oligotherapeutics.org/the-so…
#ots #oligotherapeutics #oligonucleotidetherapeutics
Laura Sepp-Lorenzino retweeted
Thank you to all our members who voted in the recent election!
We are pleased to announce the new OTS BOD for the 2026-2027 term.
2026-2027 OTS Board of Directors
Learn more about our new BOD at
oligotherapeutics.org/the-so…
#ots #oligotherapeutics #oligonucleotidetherapeutics
I am honored to join the Board of @ask_bio Inc. during such a pivotal moment as it advances its clinical and pre-clinical programs toward major milestones. Eager to help realize the full potential of these groundbreaking medicines!
#CGT #genetherapy #AAV #BOD
We’re proud to welcome Dr. Laura Sepp-Lorenzino to AskBio’s Board of Directors! With 30+ years of leadership in biotech, her insights will be key as we advance our clinical and pre-clinical #GeneTherapy candidates.
Learn more: bit.ly/4crLjQj
#AskBio #Leadership
$NTLA announces its 2025 goals to support the company’s mission to transform the lives of patients and bring forth a new era in medicine: tinyurl.com/3yepvz89
#CRISPR #GeneEditing
We made the tough call to restructure our business operations, affecting many of our skilled colleagues. I am committed to supporting them through this transition and serving as a personal reference where I can. Your consideration is greatly appreciated. #ONEintellia #talent
$NTLA announces its 2025 goals to support the company’s mission to transform the lives of patients and bring forth a new era in medicine: tinyurl.com/3yepvz89
#CRISPR #GeneEditing
Wishing you a year filled with positivity, creativity, and a commitment to making the world a better place. Let's embrace each day with a spirit of discovery and a drive to create beauty around us. Here's to a year of growth, kindness, and meaningful contributions. #NewYear2025
nex z NEJM article: nejm.org/doi/full/10.1056/NE…
Impressive data update from our nex-z program (aka NTLA-2001 for #ATTR)! Congrats to all! Teamwork makes the dream work. #OneIntellia
Impressive data update from our nex-z program (aka NTLA-2001 for #ATTR)! Congrats to all! Teamwork makes the dream work. #OneIntellia
#ATTR News: $NTLA announces positive new clinical data from the ongoing Phase 1 trial of nexiguran ziclumeran (nex-z) in patients with #ATTR amyloidosis with cardiomyopathy. Full details here: tinyurl.com/33buvne7. Join us at 12 p.m. ET for a webcast discussing the data, as well as an update from the ongoing Phase 1 polyneuropathy cohort. event.choruscall.com/mediafr…
#CRISPR #GeneEditing
This encouraging data update brings us one step closer to making CRISPR-based medicines a reality through innovative science. Excited for the future as we continue to move forward!
#HAE #CRISPR #OneIntellia
#HAE $NTLA News: Intellia presents positive results from the Phase 2 study of NTLA-2002 for #hereditaryangioedema at the @ACAAI Scientific Meeting in Boston. Details here: ir.intelliatx.com/news-relea…
Laura Sepp-Lorenzino retweeted
#HAE $NTLA News: Intellia presents positive results from the Phase 2 study of NTLA-2002 for #hereditaryangioedema at the @ACAAI Scientific Meeting in Boston. Details here: ir.intelliatx.com/news-relea…
Round of applause to the $NTLA team today!
Great news from our #AATDProgram Congratulations!
#CRISPR #GeneEditing
NEWS: $NTLA receives authorization by the @MHRAgovuk to initiate a Phase 1/2 of NTLA-3001 for the treatment of #alpha1 antitrypsin deficiency-associated lung disease. This is Intellia's first wholly owned in vivo gene insertion program. ir.intelliatx.com/news-relea…
#CRISPR #AATD
Thank you @bradloncar for the opportunity to talk about how $NTLA is advancing the field of #geneediting medicines!
Company News: @intelliatx's Chief Scientific Officer elaborates on the news that the company successfully redosed patients with a CRISPR-based and LNP delivered therapy. $NTLA
Full video: biotechtv.com/post/intellia-…
What a great time to be at Intellia! More good news from our NTLA-2002 program for #hereditaryangioedema. Congrats to the team! #CRISPR #OneIntellia
Intellia announces positive long-term data from its ongoing Phase 1 study of NTLA-2002 for #hereditaryangioedema at @EAACI_HQ 2024 Congress. Full details here: ir.intelliatx.com/news-relea…
#HAE #CRISPR #geneediting
Heartfelt congratulations to Professor José M. Polo on being elected as Fellow of the Australian Academy of Sciences!!!
science.org.au/news-and-even…
Learn more about José's research here: researchers.adelaide.edu.au/…
I’m so proud of you!!! #proudaunt
Significant milestone achieved! Our first patient has been dosed in the MAGNITUDE study for #ATTR. Congrats to the team!
#CRISPR #GeneEditing
#ATTR News: Intellia doses the first patient in its Phase 3 MAGNITUDE study of NTLA-2001 for the potential treatment of #transthyretinamyloidosis with cardiomyopathy: ir.intelliatx.com/news-relea…
#GeneEditing #CRISPR
Delivery, delivery, delivery!
Join us in Siracusa, Italy from April 4-7 to discuss new advances in nucleic acid delivery and how to solve the remaining challenges! Don't miss this opportunity. Abstract deadline is March 15, 2024. Register here:
engconf.us/conferences/biote…
Laura Sepp-Lorenzino retweeted
$NTLA News: This morning, Intellia announced a strategic collaboration with @ReCodeTx to develop novel #geneeditingtherapies for #cysticfibrosis. Full details here: ir.intelliatx.com/news-relea…
#CRISPR #CF
Laura Sepp-Lorenzino retweeted
Huge congratulations to @VertexPharma and @CRISPRTX for making history with the first-ever FDA approval of a #CRISPR therapy!
Congratulations to @VertexPharma and @CRISPRTX on FDA’s approval of @Casgevy (exa-cell), and to all who contributed to this momentous approval! fda.gov/news-events/press-an…